Blue Heron Capital Company Profile

11:01 EDT 24th June 2018 | BioPortfolio

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. We focus on investing in growth equity and lower market buyout opportunities. Blue Heron only invests in companies where someone from our network adds real and relevant value. Once committed to a deal, our value-added lead investor represents our firm as a board member to help drive company growth. Our commitment is to build fruitful and sustainable partnerships between management and our investor network. To learn more, please visit

News Articles [984 Associated News Articles listed on BioPortfolio]

Heron leaps on strong results for anesthetic product

Shares of US biotech firm Heron Therapeutics climbed 32% to $28.50 in early US trading Monday after…

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

Shire’s Japanese takeover confirmed, but what does it say about London’s blue-chips?

Deal capital is clearly sloshing around blue-chip boardrooms, but, are we seeing a run of takeovers near the top of the market?

Heron's non-opioid pain drug succeeds in Phase 3, lifting shares

Treatment with HTX-011 following surgery reduced both pain intensity and need for opioids — results Heron hopes can secure a broad label from the FDA.

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary endpoints in Phase 3 studies investigating its efficacy in relieving pain and opio...

4 BCBS plans now cover Interpace's molecular thyroid tests

Blue Cross Blue Shield of Arizona, Blue Cross Blue Shield of South Carolina, Wellmark Blue Cross Blue Shield of South Dakota  -More- 

Heron Therapeutics Announces Proposed Public Offering of Common Stock

Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some...

Brii Bio Starts Operations with $260 Million to Bring Drugs to China

Brii Bio, a China-US startup, raised $260 million in initial capital to bring innovative drugs to China. So far, Brii has options on China rights to four biotech infectious disease assets from Vir of ...

PubMed Articles [503 Associated PubMed Articles listed on BioPortfolio]

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Clinical Trials [254 Associated Clinical Trials listed on BioPortfolio]

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

The goal of this clinical research study is to compare methylene blue (an oral rinse) to standard therapy to learn if one is better, the same, or worse than the other in controlling mucosi...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Evaluation of Effectiveness of Blue Code Team After In-hospital Cardiopulmonary Arrest

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2016-2017. Primary outcome: an examination of the survival...

Interaction Between Anaesthetics and Methylene Blue

We hypothesized that pre-treatment with methylene blue could potentiate the effects of general anaesthetic agents in patients undergoing parathyroidectomy

Breast Lymph Node Mapping

The purpose of this study is to map the arm lymphatic drainage system in the axilla with blue dye and the breast drainage system with a radioactive material. By identifying the arm lymphat...

Companies [1330 Associated Companies listed on BioPortfolio]

Blue Heron Biotechnology Incorporated

Blue Heron produces and sells high quality custom reagents for life science research using its proprietary high-throughput manufacturing technologies. Blue Heron's first service, GeneMaker, makes perf...

Blue Heron Capital

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. We...


Blue Heron Bio's GeneMaker® can synthesize any gene regardless of sequence, complexity, or size with 100% accuracy. Save time and money by ordering perfect clones from Blue Heron Bio. Go to ORDERING ...

Heron Health

HERON is a privately held healthcare consultancy founded in the UK in 1999 by Paul Howard, John Kerrigan, and Chris Knight. Following over a decade of growth, the Company is still wholly owned and o...

Blue Wolf Capital Partners LLC

Blue Wolf Capital Partners LLC is a private equity firm that invests in companies in which effective management of relationships with complex constituencies, such as government an...

More Information about "Blue Heron Capital" on BioPortfolio

We have published hundreds of Blue Heron Capital news stories on BioPortfolio along with dozens of Blue Heron Capital Clinical Trials and PubMed Articles about Blue Heron Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Blue Heron Capital Companies in our database. You can also find out about relevant Blue Heron Capital Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record